Speaker Profile
PhD, CEO, GeroAI
Biography
Co-founder of Gero, a data-driven longevity biotech company that develops new drugs against aging and other complex diseases using AI-platform. An author of 75+ published papers in multiple domain areas, including publications in Science and Nature Communications. Ph.D. from the University of Amsterdam.
AI & Data Science Showcase:
Gero.AI
Gero is an AI-driven drug discovery company focused on therapies targeting aging and age-related diseases.
GERO AI: Drug Discovery Against Complex Diseases
Gero has developed a platform for targets and biomarkers of aging identification. Recently Gero demonstrated outstanding results rejuvenating mice and extending their maximum lifespan in the lab of one of the top researchers in the field - Brian Kennedy.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
